Central Nervous System Cancer
📧 Sign up to get email alerts when something new happens for Central Nervous System Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 [Phase 2]
Phase 2 clinical trial evaluating [C-11]-CS1P1 for inflammation in primary and secondary central nervous system malignancies, currently recr…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Cancer Genetic Testing in Ethnic Populations [NA]
A Mayo Clinic-sponsored clinical trial update on cancer genetic testing across multiple cancer types in diverse ethnic populations; the stud…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Short Course Radiotherapy [NA]
This clinical trial update notes a NOT_YET_RECRUITING study on short course radiotherapy for central nervous system cancer.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System [NA]
This clinical trial proposes teleconsultation care by a Psychological Support Nurse to address psychological distress in patients with prima…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
This clinical trial collects data to evaluate acute and late normal-tissue effects in patients treated with proton therapy across multiple c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Study of Stored Tumor Samples in Young Patients With Brain Tumors
Clinical trial update indicates that the study of stored tumor samples from young patients with brain tumors conducted at St. Jude has been …
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: CNS Qualitative Interview
A CNS cancer trial at University of Colorado, Denver focusing on qualitative interviews is currently recruiting (NCT05219149).
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas [Phase 2]
Phase II trial of perifosine for recurrent/progressive malignant gliomas completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 [NA]
A terminated clinical trial evaluating an iodine-131–labeled monoclonal antibody (8H9) for central nervous system cancers and neuroblastoma …
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Study of D-Methadone in Patients With Chronic Pain [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating D-Methadone in patients with chronic pain and various cancers has completed enrollment with results po…
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: Cyberknife Radiosurgery and Quality of Life
The clinical trial evaluating Cyberknife radiosurgery for bone cancer and central nervous system cancer was terminated; the update notes the…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma [Phase 2]
Phase II trial of sunitinib in patients with recurrent or inoperable meningioma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors [Phase 2]
Phase 2 trial evaluating the combination of tamoxifen, carboplatin, and topotecan in patients with brain or spinal CNS tumors; the study sta…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors [Phase 1]
This early-phase trial assesses the safety and feasibility of combining irinotecan and thalidomide in patients with recurrent central nervou…